Table 7.

HRs and 95% CIs for 1-yr mortality, ischemic stroke, hemorrhagic stroke, calciphylaxis, and GI bleeding by warfarin among the incident HD population with AF, 2006–2013

VariableMortalityaIschemicHemorrhagicCalciphylaxisGI Bleeding
aHR95% CIaHR95% CIaHR95% CIaHR95% CIaHR95% CI
Warfarin0.810.72 to 0.910.790.66 to 0.951.221.03 to 1.461.491.05 to 1.911.120.94 to 1.36
  • Adjusted for age, sex, race/ethnicity, dual eligibility, residential area, vintage, median income+CHA2DS2-VASc+baseline and time-varying comorbidities (congestive heart failure, cancer, peripheral vascular disease, cerebrovascular disease, COPD, hypertension, current smoker status, atherosclerotic heart disease, diabetes, AIDS)+baseline and time-varying medications+baseline and time-varying procedures. aHR, adjusted hazard ratio.COPD, chronic obstructive pulmonary disease.

  • a Employed a competing-risks Cox model with time-varying covariates.